Muhammad Akbar, MD
Interventional Cardiology · Evanston, ILNPI 1952513335
Payments from drug & device makers
Across 21 payments — averaging $76.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$642
- Abiomed$312
- Edwards Lifesciences$148
- Cardiovascular Systems Inc.$122
- BD$99
- Siemens Medical Solutions USA, Inc.$68
- plus $213 from 8 others
What the payments were for
- Consulting fees$35722%
- Travel & lodging$59737%
- Food & beverage$65041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 3 | $642 |
| Abiomed | 1 | $312 |
| Edwards Lifesciences | 1 | $148 |
| Cardiovascular Systems Inc. | 2 | $122 |
| BD | 3 | $99 |
| Siemens Medical Solutions USA, Inc. | 1 | $68 |
| Boston Scientific | 2 | $55 |
| Chiesi USA, Inc. | 2 | $45 |
| Medtronic | 1 | $33 |
| Biotronik Inc. | 1 | $23 |
| Livanova USA, Inc. | 1 | $22 |
| Osprey Medical Inc | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,604 in reported general payments places this provider in the 15th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 60 | $72,012 |
| EntrestoSacubitril/Valsartan | 29 | $44,804 |
| JardianceEmpagliflozin | 16 | $19,313 |
| Repatha SureclickEvolocumab | 13 | $19,293 |
| BrilintaTicagrelor | 12 | $7,694 |
| Metoprolol Succinate | 173 | $2,680 |
| Atorvastatin Calcium | 171 | $1,593 |
| SotalolSotalol Hcl | 39 | $1,248 |
| Rosuvastatin Calcium | 82 | $1,211 |
| Ezetimibe | 52 | $977 |
| Losartan Potassium | 94 | $964 |
| Nifedipine ErNifedipine | 30 | $843 |
| Amlodipine Besylate | 110 | $665 |
| ClopidogrelClopidogrel Bisulfate | 58 | $538 |
| Carvedilol | 66 | $497 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Evanston
- Mark RicciardiEvanston$2.2M
- Justin LevisayEvanston$837K
- Ted FeldmanEvanston$376K
- Jonathan RosenbergEvanston$61K
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Atman ShahChicago$794K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.